Karnataka High Court quashes drug price control case against MedPlus, holding that an allegation of seven tablets supplied against eight billed, with Rs 1.12 collected extra, is not a sale above the ceiling or label price under Clause 26 of the Drugs (Price Control) Order, 2013.

Bengaluru: Criminal proceedings against pharmacy retail chain MedPlus and its officials, arising from an alleged short supply of one tablet and an excess collection of Rs 1.12 from a customer, have been quashed by the Karnataka High Court, which found that the essential ingredient of the offence under Clause 26 of the Drugs (Price Control) Order, 2013 was not made out. [P. Srinivas & Anr. v. State of Karnataka, with M/s MedPlus & Ors. v. State of Karnataka]
Allowing two criminal petitions filed under Section 482 of the Code of Criminal Procedure, a single bench of Justice S Vishwajith Shetty quashed the entire proceedings in C.C. No. 7712/2019 pending before the III Additional Chief Metropolitan Magistrate, Bengaluru. The oral order is dated November 13, 2026.
The rule at the centre of the case
Clause 26 of the 2013 Order, as reproduced by the Court, reads:
“26. Control of sale prices of formulations.– No person shall sell any formulation to any consumer at a price exceeding the price specified in the current price list or price indicated on the label of the container or pack thereof, whichever is less.”
According to Justice Vishwajith Shetty, the provision is attracted only when a formulation is sold to a consumer above the price in the price list or on the label, whichever is lower.
A tablet short, Rs 1.12 extra
The case began with a private complaint by the Assistant Drugs Controller-I, Bengaluru Circle-4. As per that complaint, MedPlus supplied Lanzol Junior 15 mg tablets on August 23, 2016 to Shrinath Joshi, a Senior Reporter with ETV Kannada News, Bengaluru.
Joshi lodged a complaint on August 26, 2016, alleging that the bill charged Rs 40.32 for eight tablets, yet only seven were supplied and an excess amount of Rs 1.12 was collected.
On that basis, the Assistant Drugs Controller filed a private complaint invoking Clause 26 of the Drugs (Price Control) Order, 2013, read with Sections 7 and 11 of the Essential Commodities Act, 1955.
The petitioners
MedPlus directors P. Srinivas and M. Surendranath, arraigned as accused nos. 3 and 4, filed one of the petitions. The connected petition came from M/s MedPlus (a unit of Rite Med Pharma Retail Pvt. Ltd.), its authorised signatory Sudhakar Reddy and person in charge Rangaswamy K, arraigned as accused nos. 1, 2 and 5.
Why the prosecution could not stand
Short supply, and not overpricing, was all that the prosecution’s case amounted to, the Bench noted. It observed:
“It is not the case of the prosecution that the accused persons had collected excess amount than the price indicated on the label of the container or pack thereof, whichever is less. Under the circumstances, I am of the opinion that prosecution of the petitioners for the aforesaid offences would not only cause embarassment to them, but would also amount to abuse of process of law.”
Both petitions were allowed, and the entire proceedings in C.C. No. 7712/2019 were quashed for the offences under Clause 26 of the Drugs (Price Control) Order, 2013 and Section 7(1)(a)(ii) of the Essential Commodities Act, 1955.
What the order means
A complaint about the number of tablets handed over is not the same as a price control offence. Under Clause 26, what counts is the price at which a formulation is sold against the notified ceiling or label price. Without an allegation that the medicine itself was priced above the permissible limit, such a dispute cannot by itself sustain a prosecution under the Drugs (Price Control) Order read with the Essential Commodities Act.
The order also shows the Court’s readiness to close criminal cases that have stayed pending for years over trivial sums where the statutory ingredients are missing. This complaint concerned Rs 1.12 and a purchase made in 2016.
ALSO READ: Why Not Cap Medicine MRP At 16% Above Retailer Price? Supreme Court Questions Centre
Case Title: P. Srinivas & Anr. v. State of Karnataka (Crl.P. No. 355 of 2023), connected with M/s MedPlus & Ors. v. State of Karnataka (Crl.P. No. 447 of 2023)
Neutral Citation: 2026:KHC:63320
Bench: Justice S Vishwajith Shetty
Date of Order: November 13, 2026
Appearances: Advocate Akki Manjunath Gowda K for the petitioners; High Court Government Pleader Rahul Rai K for the State
